Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial
Title:
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial
Author:
Schweighardt, Becky Tompkins, Troy Lau, Kelly Jesaitis, Lynne Qi, Yulan Musson, Donald G. Farmer, Pamela Haller, Christine Shaywitz, Adam J. Yang, Ke O’Neill, Charles A.